Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +54.01%
#3 Glidr Glidr +41.01%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +27.54%
#6 Humanity Humanity +25.25%
#7 Enso Enso +17.24%
#8 Tutorial Tutorial +15.94%
#9 The Black Bull The Black Bull +14.95%
#10 Codatta Codatta +14.84%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
주식 순위 #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
주가
$0.069
마지막 동기화: 2024-07-22
시가총액
$2.06M
변동 (1일)
-1.43%
변동 (1년)
0.00%
국가
US
거래 DermTech, Inc. (DMTK)

카테고리

Healthcare
DermTech, Inc. (DMTK)의 영업이익률
August 2026 기준 영업이익률 TTM: -678.21%
DermTech, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 -678.21%입니다. 2022년 말 기준 영업이익률은 -813.92%였습니다.
DermTech, Inc.의 영업이익률 기록 (2016 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) -678.21% 0.00%
2023 -678.21% -16.67%
2022 -813.92% 24.49%
2021 -653.81% 9.03%
2020 -599.64% 14.58%
2019 -523.34% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
17.69% -100.03%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
20.42% -100.03%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00% -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
-10.70% -99.98%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
32.03% -100.05%
US
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.